Sysop: 1 revision imported

2025-11-01T14:15:28Z

1 revision imported

← Older revision	Revision as of 14:15, 1 November 2025
(No difference)

en>Isaak: Make insufflated route expanded by default.

2023-09-03T18:42:18Z

Make insufflated route expanded by default.

New page

{{SubstanceBox


|displayClasses={{{displayClasses|}}}
|MaterialTable_MaxWidth=250px
|MaterialTable_Title={{PAGENAME}}


|ModuleSource=false
|ModuleCombination=false
|ModuleStructure=true
|ModuleNomenclature=true
|ModuleClassMembership=true
|ModuleROA=true


|PhotoImageFile=
|PhotoImageWidth=
|PhotoImageCaption=


|CombinationImage1_Caption=
|CombinationImage1_File=
|CombinationImage1_Width=

|CombinationImage2_Caption=
|CombinationImage2_File=
|CombinationImage2_Width=

|CombinationImage3_Caption=
|CombinationImage3_File=
|CombinationImage3_Width=


|MolecularStructureCaption=Molecular structure of buprenorphine
|SkeletalImageFile=File:Buprenorphine.svg
|SkeletalImageWidth=245px
|3DImageFile=
|3DImageWidth=200px


|NameCommon=[[common name::Buprenex]], [[common name::Subutex]], [[common name::Butrans]], [[common name::Cizdol]], [[common name::Addnok]], [[common name::Transtec]]
|NameSubstitution=
|NameSystematic=(2S)-2-[(5R,6R,7R,14S)-9α-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol


|EffectClass=[[psychoactive class::Opioid]]
|ChemicalClass=[[chemical class::Morphinan]]



|InsufflatedROA=true
|InsufflatedROA_Collapsed=false
|InsufflatedROA_Caption=
|InsufflatedROA_Bioavailability=48%<ref name="Eriksen1989">{{cite journal | vauthors=((Eriksen, J.)), ((Jensen, N. H.)), ((Kamp-Jensen, M.)), ((Bjarnø, H.)), ((Friis, P.)), ((Brewster, D.)) | journal=The Journal of Pharmacy and Pharmacology | title=The systemic availability of buprenorphine administered by nasal spray | volume=41 | issue=11 | pages=803–805 | date= November 1989 | issn=0022-3573 | doi=10.1111/j.2042-7158.1989.tb06374.x}}</ref>
|InsufflatedROA_Threshold=< [[Insufflated threshold dose::0.2]] [[Insufflated dose units::mg]]
|InsufflatedROA_Light=[[Insufflated min light dose::0.2]] - [[Insufflated max light dose::0.4]] mg
|InsufflatedROA_Common=[[Insufflated min common dose::0.4]] - [[Insufflated max common dose::0.8]] mg
|InsufflatedROA_Strong=[[Insufflated min strong dose::0.8]] - [[Insufflated max strong dose::1.5]] mg
|InsufflatedROA_Heavy=[[Insufflated heavy dose::1.5]] mg +
|InsufflatedROA_TimelineFile=
|InsufflatedROA_TimelineWidth=
|InsufflatedROA_Duration=[[Insufflated min total time::8]] - [[Insufflated max total time::14]] [[Insufflated total time units::hours]]
|InsufflatedROA_Onset=[[Insufflated min onset time::30]] - [[Insufflated max onset time::60]] [[Insufflated onset time units::minutes]]
|InsufflatedROA_Peak=[[Insufflated min peak time::4]] - [[Insufflated max peak time::8]] [[Insufflated peak time units::hours]]
|InsufflatedROA_Offset=
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::1]] - [[Insufflated max afterglow time::3]] [[Insufflated afterglow time units::days]]

|SublingualROA=true
|SublingualROA_Collapsed=true
|SublingualROA_Caption=
|SublingualROA_Bioavailability= 30%<ref name="Mendelson1997">{{cite journal | vauthors=((Mendelson, J.)), ((Upton, R. A.)), ((Everhart, E. T.)), ((Jacob, P.)), ((Jones, R. T.)) | journal=Journal of Clinical Pharmacology | title=Bioavailability of sublingual buprenorphine | volume=37 | issue=1 | pages=31–37 | date= January 1997 | issn=0091-2700 | doi=10.1177/009127009703700106}}</ref>
|SublingualROA_Threshold=<=[[Sublingual threshold dose::0.3]] [[Sublingual dose units::mg]]
|SublingualROA_Light=[[Sublingual min light dose::1]] - [[Sublingual max light dose::2]] mg
|SublingualROA_Common=[[Sublingual min common dose::2]] - [[Sublingual max common dose::4]] mg
|SublingualROA_Strong=[[Sublingual min strong dose::4]] - [[Sublingual max strong dose::8]] mg
|SublingualROA_Heavy=[[Sublingual heavy dose::8]]mg +
|SublingualROA_TimelineFile=
|SublingualROA_TimelineWidth=
|SublingualROA_Duration=[[Sublingual min total time::18]] - [[Sublingual max total time::24]] [[Sublingual total time units::hours]]
|SublingualROA_Onset=[[Sublingual min onset time::40]] - [[Sublingual max onset time::80]] [[Sublingual onset time units::minutes]]
|SublingualROA_Peak=[[Sublingual min peak time::1.5]] - [[Sublingual max peak time::2]] [[Sublingual peak time units::hours]]
|SublingualROA_Aftereffects=[[Sublingual min afterglow time::1]] - [[Sublingual max afterglow time::3]] [[Sublingual afterglow time units::days]]

}}

Template:SubstanceBox/Buprenorphine - Revision history

Sysop: 1 revision imported

en>Isaak: Make insufflated route expanded by default.